Research ArticleSestamibi and Teboroxime
A Review of Cardiac Imaging with Sestamibi and Teboroxime
Jeffrey A. Leppo, E. Gordon DePuey and Lynne L. Johnson
Journal of Nuclear Medicine October 1991, 32 (10) 2012-2022;
Jeffrey A. Leppo
E. Gordon DePuey
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
A Review of Cardiac Imaging with Sestamibi and Teboroxime
Jeffrey A. Leppo, E. Gordon DePuey, Lynne L. Johnson
Journal of Nuclear Medicine Oct 1991, 32 (10) 2012-2022;
Jump to section
Related Articles
- No related articles found.
Cited By...
- From 201Tl to 99mTc-Sestamibi (perspective on "Technetium-99m Hexakis 2-Methoxyisobutyl Isonitrile: Human Biodistribution, Dosimetry, Safety, and Preliminary Comparison To Thallium-201 for Myocardial Perfusion Imaging" J Nucl Med. 1989;30:301-311)
- 99mTc-N-DBODC5, a New Myocardial Perfusion Imaging Agent with Rapid Liver Clearance: Comparison with 99mTc-Sestamibi and 99mTc-Tetrofosmin in Rats
- Assessment of regional and global left ventricular function by reinjection Tl-201 and rest Tc-99m sestamibi ECG-gated SPECT: Comparison with three-dimensional magnetic resonance imaging
- Validation of global and segmental left ventricular contractile function using gated planar technetium-99m sestamibi myocardial perfusion imaging